 | Up a level |
Number of items: 1.
Stollenwerk, B., Le, L., Zindel, S., Mueller, D., Klug, F. and Stock, S. (2013). A SOCIETAL PERSPECTIVE COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN SODIUM IN PATIENTS UNDERGOING TOTAL HIP OR TOTAL KNEE REPLACEMENT SURGERY. Value Health, 16 (7). S. A530 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733